PreveCeutical develops proprietary method for extracting cannabinoids for Sol-gel

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on email
Email



PreveCeutical Medical INC. (CSE:PREV) CEO and President Stephen Van Deventer joined Steve Darling in the Vancouver studio of Proactive Investors to talk about the companies recent news that they had successfully optimized the conditions for extracting cannabinoids from one of its cannabis strains and developed a proprietary method for the accurate measurement of cannabinoids.

Van Deventer also shared details of their duel gene therapy program that deals with diabetes and obesity.

View original source video by clicking here

On Key

Related Posts